logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Rocky Mountain Cancer Centers - Pueblo

+17192966000
Source: Site record.
https://www.rockymountaincancercenters.com/locations/pueblo

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Trial-derived.
134Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
59Active Trials
Source: Trial-derived.
57Completed Trials
Source: Trial-derived.
713Unique Conditions
Source: Trial-derived.
48Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Recurrent Squamous Cell Lung Carcinoma (8)Source: Trial-derived. Breast Cancer (6)Source: Trial-derived. Recurrent Breast Carcinoma (6)Source: Trial-derived. Stage IV Squamous Cell Lung Carcinoma AJCC v7 (6)Source: Trial-derived. Recurrent Ovarian Carcinoma (5)Source: Trial-derived. Stage IIIA Breast Cancer (5)Source: Trial-derived. HER2/Neu Negative (4)Source: Trial-derived. Recurrent Lung Non-Small Cell Carcinoma (4)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (111)Source: Trial-derived. SWOG Cancer Research Network (27)Source: Trial-derived. NRG Oncology (15)Source: Trial-derived. Alliance for Clinical Trials in Oncology (14)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (8)Source: Trial-derived. Canadian Cancer Trials Group (6)Source: Trial-derived. Pfizer (6)Source: Trial-derived. Gilead Sciences (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Coordination with local labs / imaging
Source: AI-inferred. Remote informed consent

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. X-Ray
Source: AI-inferred. 12-lead ECG

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Apheresis

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Electronic trial enrollment system
Source: AI-inferred. Fluorescence in situ hybridization (FISH) cytogenetic testing
Source: AI-inferred. HIV viral load testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Tumour BRAF V600 mutation testing
Source: AI-inferred. Tumour response imaging